Skip to main content
Premium Trial:

Request an Annual Quote

Health Discovery, Teranode, Sun Microsystems

Premium

Health Discovery Acquires Patents for SVMs in Medicine

Health Discovery Corporation said last week that it has acquired the rights to a portfolio of 71 patents and pending patent applications on support vector machines and other machine-learning tools with applications in diagnostics and drug discovery


Teranode Secures $2.6M Series A Round

Teranode said last week that it as closed a $2.6M Series A round of financing led by Ignition Partners. Teranode’s existing investors — the Washington Research Foundation and Prima Electronics — also participated in the funding round.

The Seattle-based firm markets the VLX Design Suite, a biological modeling and experimental design platform. The company’s customers include Pfizer, AstraZeneca, Fred Hutchinson Cancer Research Center, and St. Jude’s Hospital.

Teranode said that its previous funding includes a $1.8 million NIH grant, “undiluted funds” from the NSF and Intel Research, seed funding from the Washington Research foundation, and private investors.

The cash will help expand its development and support teams and invest in marketing and partnerships.


Sun Seeks Papers for Comp Bio Conference

Sun Microsystems has issued a call for papers for a conference it is organizing at its computational biology Center of Excellence in Research Triangle Park, NC, Oct. 28-29.

The conference, “Bridging Knowledge Gaps in Computational Biology,” will address several “bridges” necessary for advancing computational biology, according to the organizers, including data technologies for handling distributed data, ontologies and pathway representations, and commercial applications for computational biology research.

The call for papers expires Sept. 10. Abstracts can be sent to [email protected].

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.